3,198
Views
3
CrossRef citations to date
0
Altmetric
Musculoskeletal

The cost-effectiveness of abobotulinumtoxinA (Dysport) and onabotulinumtoxinA (Botox) for managing spasticity of the upper and lower limbs, and cervical dystonia

, &
Pages 919-929 | Received 11 Mar 2022, Accepted 17 Jun 2022, Published online: 15 Jul 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.